Recursion Pharmaceuticals, Inc.RXRXNASDAQ
Loading
Enterprise value to EBITDA ratio
Latest
-2.08
↑ 87% vs avg
Percentile
P100
Near historical high
Streak
2 yr
Consecutive growthExpanding
Average
-16.20
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | -2.08 | +35.0% |
| 2024 | -3.21 | +42.3% |
| 2023 | -5.55 | -48.0% |
| 2022 | -3.75 | +75.1% |
| 2021 | -15.09 | +55.0% |
| 2020 | -33.51 | +33.3% |
| 2019 | -50.24 | - |